Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Phosholipases, nucleic acids encoding them and methods for making and using them

Active Publication Date: 2005-05-19
DSM IP ASSETS BV
View PDF8 Cites 53 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0013] The invention provides isolated or recombinant nucleic acids comprising a nucleic acid sequence having at least about 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or more, or complete (100%) sequence identity to an exemplary nucleic acid of the invention, e.g., SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO:41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO:61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO:69, SEQ ID NO:71, SEQ ID NO:73, SEQ ID NO:75, SEQ ID NO:77, SEQ ID

Problems solved by technology

The neutralization process is highly effective in removing free fatty acids and phospholipids but this process also results in significant yield losses and sacrifices in quality.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phosholipases, nucleic acids encoding them and methods for making and using them
  • Phosholipases, nucleic acids encoding them and methods for making and using them
  • Phosholipases, nucleic acids encoding them and methods for making and using them

Examples

Experimental program
Comparison scheme
Effect test

example 1

Blast Program Used for Sequence Identify Profiling

[0502] This example describes an exemplary sequence identity program to determine if a nucleic acid is within the scope of the invention. An NCBI BLAST 2.2.2 program is used, default options to blastp. All default values were used except for the default filtering setting (i.e., all parameters set to default except filtering which is set to OFF); in its place a “−F F” setting is used, which disables filtering. Use of default filtering often results in Karlin-Altschul violations due to short length of sequence. The default values used in this example:

 “Filter for low complexity: ON> Word Size: 3> Matrix: Blosum62> Gap Costs: Existence:11> Extension:1”

[0503] Other default settings were: filter for low complexity OFF, word size of 3 for protein, BLOSUM62 matrix, gap existence penalty of −11 and a gap extension penalty of −1. The “−W” option was set to default to 0. This means that, if not set, the word size defaults to 3 for proteins ...

example 2

Simulation of PLC Mediated Degumming

[0504] This example describes the simulation of phospholipase C (PLC)-mediated degumming.

[0505] Due to its poor solubility in water phosphatidylcholine (PC) was originally dissolved in ethanol (100 mg / ml). For initial testing, a stock solution of PC in 50 mM 3-morpholinopropanesulpholic acid or 60 mM citric acid / NaOH at pH 6 was prepared. The PC stock solution (10 μl, 1 μg / μl) was added to 500 μl of refined soybean oil (2% water) in an Eppendorf tube. To generate an emulsion the content of the tube was mixed for 3 min by vortexing (see FIG. 5A). The oil and the water phase were separated by centrifugation for 1 min at 13,000 rpm (FIG. 5B). The reaction tubes were pre-incubated at the desired temperature (37° C., 50° C., or 60° C.) and 3 μl of PLC from Bacillus cereus (0.9 U / μl) were added to the water phase (FIG. 5C). The disappearance of PC was analyzed by TLC using chloroform / methanol / water (65:25:4) as a solvent system (see, e.g., Taguchi (1...

example 3

Expression of Phospholipases

[0507] This example describes the construction of a commercial production strain of the invention that can express multiple phospholipases (including enzymes of the invention). In order to produce a multi-enzyme formulation suitable for use in the degumming of food-grade vegetable oils (including soybean, canola, and sunflower), a recombinant expression strain can be generated that expresses two different phospholipase sequences in the same expression host. For example, this strain may be constructed to contain one or more copies of a PLC gene and one or more copies of a phosphatidylinositol-PLC gene. These genes may exist on one plasmid, multiple plasmids, or the genes may be inserted into the genome of the expression host by homologous recombination. When the genes are introduced by homologous recombination, the genes may be introduced into a single site in the host genome as a DNA expression cassette that contains one or more copies of both genes. Alt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Immunogenicityaaaaaaaaaa
Toxicityaaaaaaaaaa
Login to View More

Abstract

The invention provides novel polypeptides having phospholipase activity, including, e.g., phospholipase A, B, C and D activity, patatin activity, lipid acyl hydrolase (LAH) activity, nucleic acids encoding them and antibodies that bind to them. Industrial methods, e.g., oil degumming, and products comprising use of these phospholipases are also provided.

Description

RELATED APPLICATIONS [0001] This application is a continuation-in-part application (“CIP”) of U.S. patent applications Ser. No. (“U.S. Ser. No.”) 10 / 421,654, filed Apr. 21, 2003, which claims the benefit of priority under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 60 / 374,313, filed Apr. 19, 2002; and, Patent Convention Treaty (PCT) International Application Serial No. PCT / US03 / 12556, filed Apr. 21, 2003. Each of the aforementioned applications is explicitly incorporated herein by reference in its entirety and for all purposes.[0002] This application includes a compact disc (submitted in duplicate) containing a sequence listing. The entire content of the sequence listing is herein incorporated by reference. The sequence listing is identified on the compact disc as follows. File NameDate of CreationSize (bytes)Sequence Listing.txtMar. 2, 2004296,960 bytesFIELD OF THE INVENTION [0003] This invention relates generally to phospholipase enzymes, polynucleotides encoding the e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/16
CPCC07K2319/00C12N9/16C12N9/18C12P7/6481C12N15/8242C12N15/8247C12P7/6418C12N9/20A61P3/06A61P43/00C12P7/6458
Inventor GRAMATIKOVA, SVETLANAHAZLEWOOD, GEOFFLAM, DAVIDBARTON, NELSON
Owner DSM IP ASSETS BV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products